Copyright
©The Author(s) 2015.
World J Stem Cells. Mar 26, 2015; 7(2): 418-427
Published online Mar 26, 2015. doi: 10.4252/wjsc.v7.i2.418
Published online Mar 26, 2015. doi: 10.4252/wjsc.v7.i2.418
Marker | Cancer origin | Marker properties | Ref. |
ALDH1 | Breast | Catalyzes the oxidation of aliphatic and aromatic aldehydes | [81] |
Converts retinol to retinoic acid | |||
AdSC | |||
ABC135 | Melanomas | ATP binding cassette family | [82] |
Involved in transport of sterol and other lipids | |||
Bmi-1 | Breast, prostate, leukemias, neuroblastomas | HSC, NSC, and AdSC marker | [83,84] |
CD20 | Metastatic melanomas | Hematopoietic marker | [85] |
CD29 | Breast, colon | AdSC marker | [86,87] |
CD34 | Leukemias, sarcomas | HSC, MSC marker | [88-91] |
CD44 | Breast, pancreas, colon, head and neck, prostate | Adhesion molecule related to metastasis | [91-96] |
HSC and pluripotent stem cell marker | |||
Normal prostate epithelial stem cell marker | |||
CD49f | Prostate | Adhesion to extracellular matrix | [97] |
CD90 | Liver, breast, glioblastomas | Glycoprotein, role in stem cell differentiation | [98-100] |
MSC marker | |||
CD113 | Lung, pancreas, colon, glioblastoma, melanomas, etc. | HSC, NSC AdSC (colon) marker | [16-18,101-104] |
CD117 | Breast, ovarian, lung, glioblastoma | Progenitor cell marker | [105,106] |
Oct4 | Many carcinomas | Embryonic stem cell and induced pluripotent stem cell marker | [107,108] |
Sca-1 | Lung | Skin epithelial stem cell and HSC marker | [109] |
Cancer origin | Mitochondria features | Energy metabolism of CSC | Target/drug for CSCs | Ref. | ||
Feature | CSC | Non-CSC | ||||
Breast | Glucose uptake | High | Low | OXPHOS | [68] | |
ATP contents | High | Low | ||||
OCR | High | Low | ||||
Lactate production | Low | High | ||||
Membrane potential | High | Low | ||||
Glioma | Glucose consumption | Low | High | OXPHOS | [66] | |
ATP contents | High | Low | ||||
Lactate production | Low | High | ||||
OCR | High | Low | OXPHOS | IMP-2 | [67] | |
ATP contents | High | Low | ||||
Leukemia | ROS | Low | High | Low glycolysis | Bcl-2/ | [63] |
Proliferation rate | Slow | Fast | Low OXPHOS | ABT263 | ||
OCR | Low | High | ||||
Lactate production | Low | High | ||||
ATP contents | Low | High | ||||
Lung | Glucose consumption | Low | High | [62] | ||
OCR | Low | High | ||||
ROS level | Low | High | ||||
ATP contents | Low | High | ||||
Membrane potential | High | Low | ||||
Mitochondrial DNA | Low | High | ||||
Ovarian | NV-128 | [65] | ||||
ROS | High | Low | OXPHOS | [64] | ||
Membrane potential | High | Low | ||||
ATP contents | High | Low | ||||
Glucose deprivation | Resist | Sensitive |
- Citation: Song IS, Jeong JY, Jeong SH, Kim HK, Ko KS, Rhee BD, Kim N, Han J. Mitochondria as therapeutic targets for cancer stem cells. World J Stem Cells 2015; 7(2): 418-427
- URL: https://www.wjgnet.com/1948-0210/full/v7/i2/418.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v7.i2.418